This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sarkar, S. Articles by Reznikoff, C. A. Search for Related Content PubMed PubMed Citation Articles by Sarkar, S. Articles by Reznikoff, C. A.

Different Combinations of Genetic/Epigenetic Alterations Inactivate the p53 and pRb Pathways in Invasive Human Bladder Cancers¹

Departments of Human Oncology [S. S., K. P. J., M. S. B., D. F. J., C. A. R.], Surgery [D. F. J., T. B. G.], and Ophthalmology [R.W. N., C. P.], and the University of Wisconsin Medical School and Comprehensive Cancer Center [S. S., K. P. J., M. S. B., D. F. J., C. A. R., R. W. N., C. P.], Madison, Wisconsin 53792; Unité 434 INSERM Instituté de Génétique Moléculaire, 75010 Paris, France [V. D. V.]; Faculti des Sciences, 86100 Poitiers, France [C-J. L.]; and Cancer Research Unit, Children’s Medical Research Institute, Wentworthville, 2145 New South Wales Australia [T. R. Y.]

Inactivation of both the pRb (pRb-cyclin D1/cyclin-dependent kinase 4/6-p16) and p53 (p53-p21^WAF1-p14^ARF) pathways is thought to be essential for immortalization in vitro and malignant transformation in vivo. We identified different combinations of pRb and p53 pathway alterations in 12 invasive transitional cell carcinomas (TCCs) and addressed the functional significance of the different combinations observed. Results showed four combinations of alterations including -pRb/-p53 (i.e., pRb inactivated in the pRb pathway and p53 inactivated in the p53 pathway; four TCCs), -p16/-p53 (four TCCs), -p16/-p21^WAF1 (one TCC), and -p16/-p14^ARF (two TCCs). These groups include two new combinations (i.e., -p16/-p53 and -p16/-p21^WAF1) not reported previously for TCCs. An alteration in the key components of the p53 pathway was not detected in one invasive TCC that had inactivated p16. Note that all four TCCs with inactivated pRb had mutant p53; thus, the combinations of -pRb/-p21^WAF1 and -pRb/-p14^ARF were not observed. Only two of eight TCCs with altered p16 had concomitant p14^ARF loss, demonstrating that simultaneous inactivation of these two 9p21INK4a tumor suppressor genes is not obligatory. To determine the biological phenotypes of TCCs with different combinations of pRb and p53 pathway alterations, their downstream responses to gamma radiation were studied in vitro. As expected, none of eight TCCs with mutant p53 responded to gamma radiation by elevation of p53, p21^WAF1, or mdm2 or by cell cycle arrest. Only two of four TCCs with wild-type p53 and wild-type pRb (the combination of -p16/-p14^ARF) showed normal downstream responses to gamma radiation and underwent cell cycle arrest. Two TCCs with wild-type pRb and wild-type p53 (the combination of -p16/-p21^WAF1 and one TCC with -p16) failed to show cell cycle arrest in response to radiation. This was attributed to the absence of p21^WAF1 in one TCC. In summary, these data support a model of invasive bladder cancer pathogenesis in which both the pRb and p53 pathways are usually inactivated and the biology of the tumor is impacted by the mechanism of their inactivations.

This article has been cited by other articles:

				L. S. Pymar, F. M. Platt, J. M. Askham, E. E. Morrison, and M. A. Knowles Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms Hum. Mol. Genet., July 1, 2008; 17(13): 2006 - 2017. [Abstract] [Full Text] [PDF]

				N. J. MacLaine, M. D. Wood, J. C. Holder, R. W. Rees, and J. Southgate Sensitivity of Normal, Paramalignant, and Malignant Human Urothelial Cells to Inhibitors of the Epidermal Growth Factor Receptor Signaling Pathway Mol. Cancer Res., January 1, 2008; 6(1): 53 - 63. [Abstract] [Full Text] [PDF]

				M. Sanchez-Carbayo, N. D. Socci, T. Kirchoff, N. Erill, K. Offit, B. H. Bochner, and C. Cordon-Cardo A Polymorphism in HDM2 (SNP309) Associates with Early Onset in Superficial Tumors, TP53 Mutations, and Poor Outcome in Invasive Bladder Cancer Clin. Cancer Res., June 1, 2007; 13(11): 3215 - 3220. [Abstract] [Full Text] [PDF]

				R.A. Crallan, N.T. Georgopoulos, and J. Southgate Experimental models of human bladder carcinogenesis Carcinogenesis, March 1, 2006; 27(3): 374 - 381. [Abstract] [Full Text] [PDF]

				A. Garcia-Espana, E. Salazar, T.-T. Sun, X.-R. Wu, and A. Pellicer Differential Expression of Cell Cycle Regulators in Phenotypic Variants of Transgenically Induced Bladder Tumors: Implications for Tumor Behavior Cancer Res., February 15, 2005; 65(4): 1150 - 1157. [Abstract] [Full Text] [PDF]

				H.-S. Hsu, Y.-C. Wang, R.-C. Tseng, J.-W. Chang, J.-T. Chen, C.-M. Shih, C.-Y. Chen, and Y.-C. Wang CpG Island Methylation Is Responsible for p14ARF Inactivation and Inversely Correlates with p53 Overexpression in Resected Non-Small Cell Lung Cancer Clin. Cancer Res., July 15, 2004; 10(14): 4734 - 4741. [Abstract] [Full Text] [PDF]

				S. De Flora, R. M. Balansky, F. D'Agostini, A. Izzotti, A. Camoirano, C. Bennicelli, Z. Zhang, Y. Wang, R. A. Lubet, and M. You Molecular Alterations and Lung Tumors in p53 Mutant Mice Exposed to Cigarette Smoke Cancer Res., February 15, 2003; 63(4): 793 - 800. [Abstract] [Full Text] [PDF]

				S. R. Schwarze, S. E. DePrimo, L. M. Grabert, V. X. Fu, J. D. Brooks, and D. F. Jarrard Novel Pathways Associated with Bypassing Cellular Senescence in Human Prostate Epithelial Cells J. Biol. Chem., April 19, 2002; 277(17): 14877 - 14883. [Abstract] [Full Text] [PDF]

				J. F. Garcia, R. Villuendas, M. Sanchez-Beato, A. Sanchez-Aguilera, L. Sanchez, I. Prieto, and M. A. Piris Nucleolar p14ARF Overexpression in Reed-Sternberg Cells in Hodgkin's Lymphoma : Absence of p14ARF/Hdm2 Complexes Is Associated with Expression of Alternatively Spliced Hdm2 Transcripts Am. J. Pathol., February 1, 2002; 160(2): 569 - 578. [Abstract] [Full Text] [PDF]

				I. D.C. Markl, J. Cheng, G. Liang, D. Shibata, P. W. Laird, and P. A. Jones Global and Gene-specific Epigenetic Patterns in Human Bladder Cancer Genomes Are Relatively Stable in Vivo and in Vitro over Time Cancer Res., August 1, 2001; 61(15): 5875 - 5884. [Abstract] [Full Text] [PDF]